The specific biochemical cause of calcium stone formation can now be reliably identified in close to 80% of cases. By permitting treatment to be targeted to the underlying condition, this has, in recent years, resulted in a documented reduction in stone recurrence. Less common types of nephrolithiasis—uric acid, cystine, and struvite stone formation—are also discussed and their management outlined.